Matches in Wikidata for { <http://www.wikidata.org/entity/Q91847851> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q91847851 description "article scientifique publié en 2020" @default.
- Q91847851 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91847851 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91847851 description "scientific article published on 13 April 2020" @default.
- Q91847851 description "wetenschappelijk artikel" @default.
- Q91847851 description "наукова стаття, опублікована 13 квітня 2020" @default.
- Q91847851 name "The potential of circulating microRNA-125a and microRNA-125b as markers for inflammation and clinical response to infliximab in rheumatoid arthritis patients" @default.
- Q91847851 name "The potential of circulating microRNA-125a and microRNA-125b as markers for inflammation and clinical response to infliximab in rheumatoid arthritis patients" @default.
- Q91847851 type Item @default.
- Q91847851 label "The potential of circulating microRNA-125a and microRNA-125b as markers for inflammation and clinical response to infliximab in rheumatoid arthritis patients" @default.
- Q91847851 label "The potential of circulating microRNA-125a and microRNA-125b as markers for inflammation and clinical response to infliximab in rheumatoid arthritis patients" @default.
- Q91847851 prefLabel "The potential of circulating microRNA-125a and microRNA-125b as markers for inflammation and clinical response to infliximab in rheumatoid arthritis patients" @default.
- Q91847851 prefLabel "The potential of circulating microRNA-125a and microRNA-125b as markers for inflammation and clinical response to infliximab in rheumatoid arthritis patients" @default.
- Q91847851 P1433 Q91847851-F8E1A890-DC75-45B2-8D43-DE9B1795DCEF @default.
- Q91847851 P1476 Q91847851-F919F7C8-CA86-4B39-AF98-965F65AE9242 @default.
- Q91847851 P2093 Q91847851-76975B94-B888-4229-A410-81EC960BAED4 @default.
- Q91847851 P2860 Q91847851-0D8AFB00-60B0-4401-AB44-061CDE9F11D2 @default.
- Q91847851 P304 Q91847851-8C885484-C5CB-40D2-A93E-95F2B712F97A @default.
- Q91847851 P31 Q91847851-A4895DA7-3329-4BAE-9F12-280FD0CD8F65 @default.
- Q91847851 P356 Q91847851-3F0009B9-6BDB-4E68-8837-C694DD21A230 @default.
- Q91847851 P50 Q91847851-AE0357D6-8D1E-4C9F-BB73-E172815FE0F9 @default.
- Q91847851 P577 Q91847851-920E7035-0C8A-4AF3-8D33-AD163BF602ED @default.
- Q91847851 P698 Q91847851-E2F69112-B606-43B6-A53E-9372F9704C70 @default.
- Q91847851 P921 Q91847851-635D5826-80D1-4A23-B106-6E2051C403B6 @default.
- Q91847851 P932 Q91847851-10AFB4B0-365B-444C-ACE6-17A3F760CAF3 @default.
- Q91847851 P356 JCLA.23329 @default.
- Q91847851 P698 32281166 @default.
- Q91847851 P1433 Q15754724 @default.
- Q91847851 P1476 "The potential of circulating microRNA-125a and microRNA-125b as markers for inflammation and clinical response to infliximab in rheumatoid arthritis patients" @default.
- Q91847851 P2093 "Peng Cheng" @default.
- Q91847851 P2860 Q54632796 @default.
- Q91847851 P304 "e23329" @default.
- Q91847851 P31 Q13442814 @default.
- Q91847851 P356 "10.1002/JCLA.23329" @default.
- Q91847851 P50 Q91847845 @default.
- Q91847851 P577 "2020-04-13T00:00:00Z" @default.
- Q91847851 P698 "32281166" @default.
- Q91847851 P921 Q187255 @default.
- Q91847851 P932 "7439431" @default.